DOI QR코드

DOI QR Code

miR-19a Promotes Cell Growth and Tumorigenesis through Targeting SOCS1 in Gastric Cancer

  • Qin, Shuang (Department of General Surgery, First Affiliated Hospital of Xinxiang Medical University) ;
  • Ai, Fang (Department of Pediatric Surgery, First Affiliated Hospital of Xinxiang Medical University) ;
  • Ji, Wei-Fang (Department of Pediatric Surgery, First Affiliated Hospital of Xinxiang Medical University) ;
  • Rao, Wang (Department of Pediatric Surgery, First Affiliated Hospital of Xinxiang Medical University) ;
  • Zhang, He-Cheng (Department of Pediatric Surgery, First Affiliated Hospital of Xinxiang Medical University) ;
  • Yao, Wen-Jian (Department of Thoracic Surgery, First Affiliated Hospital of Xinxiang Medical University)
  • Published : 2013.02.28

Abstract

Accumulating evidence has shown that microRNAs are involved in cancer development and progression. However, it remains unknown about the potential role of miR-19a in the pathogenesis of gastric cancer. Here, we report that suppressor of cytokine signaling 1 (SOCS1) is a novel target of miR-19a in gastric cancer cells and that miR-19a expression is inversely correlated with SOCS1 expression in gastric cancer cells and a subset of gastric cancer tissues. Ectopic expression of miR-19a dramatically promoted proliferation and tumorigenicity of gastric cancer cells both in vitro and in vivo. Moreover, we showed that silencing of SOCS1 promoted cell growth and colony formation resembling that of miR-19a overexpression, whereas re-introduction of SOCS1 (without the 3'-UTR) attenuated the pro-tumorigenic functions. Taken together, our findings suggest that the SOCS1 gene is a direct target of miR-19a, which functions as an oncogenic miRNA in gastric cancer by repressing the expression of tumor suppressor SOCS1.

Keywords

References

  1. Bartel DP (2009). MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-33. https://doi.org/10.1016/j.cell.2009.01.002
  2. Clevenger CV (2004). Roles and regulation of stat family transcription factors in human breast cancer. Am J Pathol, 165, 1449-60. https://doi.org/10.1016/S0002-9440(10)63403-7
  3. Davey GM, Heath WR, Starr R (2006). SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation. Tissue Antigens, 67, 1-9.
  4. Ding L, Xu Y, Zhang W, et al (2010). MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res, 20, 784-93. https://doi.org/10.1038/cr.2010.79
  5. Du Y, Xu Y, Ding L, et al (2009). Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol, 44, 556-61. https://doi.org/10.1007/s00535-009-0037-7
  6. Esquela-Kerscher A, Slack FJ (2006). Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer, 6, 259-69. https://doi.org/10.1038/nrc1840
  7. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet, 9, 102-14.
  8. Friedman RC, Farh KK, Burge CB, et al (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Res, 19, 92-105.
  9. Gao C, Zhang Z, Liu W, et al (2010). Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer, 116, 41-9.
  10. Guo X, Guo L, Ji J, et al (2010). miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Biochem Biophys Res Commun, 398, 1-6. https://doi.org/10.1016/j.bbrc.2010.05.082
  11. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  12. Jiang S, Zhang HW, Lu MH, et al (2010). MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res, 70, 3119-27. https://doi.org/10.1158/0008-5472.CAN-09-4250
  13. Krebs DL, Hilton DJ (2001). SOCS proteins: negative regulators of cytokine signaling. Stem Cells, 19, 378-87. https://doi.org/10.1634/stemcells.19-5-378
  14. Lai RH, Hsiao YW, Wang MJ, et al (2010). SOCS6, down-regulated in gastric cancer, inhibits cell proliferation and colony formation. Cancer Lett, 288, 75-85. https://doi.org/10.1016/j.canlet.2009.06.025
  15. Lee TL, Yeh J, Van Waes C, et al (2006). Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas. Mol Cancer Ther, 5, 8-19.
  16. Liu M, Wang Z, Yang S, et al (2011). TNF-$\alpha$ is a novel target of miR-19a. Int J Oncol, 38, 1013-22.
  17. Oshimo Y, Kuraoka K, Nakayama H, et al (2004). Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma. Int J Cancer, 112, 1003-9. https://doi.org/10.1002/ijc.20521
  18. Ouchida M, Kanzaki H, Ito S, et al (2012). Novel direct targets of miR-19a identified in breast cancer cells by a quantitative proteomic approach. PLoS One, 7, e44095. https://doi.org/10.1371/journal.pone.0044095
  19. Pichiorri F, Suh SS, Ladetto M, et al (2008). MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci USA, 105, 12885-90. https://doi.org/10.1073/pnas.0806202105
  20. Shi Y, Zhou Y (2010). The role of surgery in the treatment of gastric cancer. J Surg Oncol, 101, 687-92. https://doi.org/10.1002/jso.21455
  21. Slattery ML, Lundgreen A, Kadlubar SA, et al (2013). JAK/STAT/SOCS-signaling pathway and colon and rectal cancer. Mol Carcinog, 52, 155-66. https://doi.org/10.1002/mc.21841
  22. Souma Y, Nishida T, Serada S, et al (2012). Antiproliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells. Int J Cancer, 131, 1287-96. https://doi.org/10.1002/ijc.27350
  23. Ueda T, Volinia S, Okumura H, et al (2010). Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol, 11, 136-46. https://doi.org/10.1016/S1470-2045(09)70343-2
  24. Wu Q, Jin H, Yang Z, et al (2010). MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun, 392, 340-45. https://doi.org/10.1016/j.bbrc.2009.12.182
  25. Xu XM, Wang XB, Chen MM, et al (2012). MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5. Cancer Lett, 322, 148-58. https://doi.org/10.1016/j.canlet.2012.02.038
  26. Zhang Z, Li Z, Gao C, et al (2008). miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest, 88, 1358-66. https://doi.org/10.1038/labinvest.2008.94

Cited by

  1. miRNA-218 Inhibits Osteosarcoma Cell Migration and Invasion by Down-regulating of TIAM1, MMP2 and MMP9 vol.14, pp.6, 2013, https://doi.org/10.7314/APJCP.2013.14.6.3681
  2. microRNA-22 acts as a metastasis suppressor by targeting metadherin in gastric cancer vol.11, pp.1, 2014, https://doi.org/10.3892/mmr.2014.2682
  3. Silencing of Suppressor of Cytokine Signaling-3 due to Methylation Results in Phosphorylation of STAT3 in Imatinib Resistant BCR-ABL Positive Chronic Myeloid Leukemia Cells vol.15, pp.11, 2014, https://doi.org/10.7314/APJCP.2014.15.11.4555
  4. Matrine alters microRNA expression profiles in SGC-7901 human gastric cancer cells vol.32, pp.5, 2014, https://doi.org/10.3892/or_xxxxxxxx
  5. MicroRNA-19a regulates lipopolysaccharide-induced endothelial cell apoptosis through modulation of apoptosis signal-regulating kinase 1 expression vol.16, pp.1, 2015, https://doi.org/10.1186/s12867-015-0034-8
  6. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer vol.21, pp.15, 2015, https://doi.org/10.3748/wjg.v21.i15.4564
  7. The functional sites of miRNAs and lncRNAs in gastric carcinogenesis vol.36, pp.2, 2015, https://doi.org/10.1007/s13277-015-3136-5
  8. Let-7b inhibits cell proliferation, migration, and invasion through targeting Cthrc1 in gastric cancer vol.36, pp.5, 2015, https://doi.org/10.1007/s13277-014-2950-5
  9. MicroRNA: master controllers of intracellular signaling pathways vol.72, pp.18, 2015, https://doi.org/10.1007/s00018-015-1940-0
  10. Effect of miR-19a and miR-21 on the JAK/STAT signaling pathway in the peripheral blood mononuclear cells of patients with systemic juvenile idiopathic arthritis vol.11, pp.6, 2016, https://doi.org/10.3892/etm.2016.3188
  11. Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer vol.22, pp.35, 2016, https://doi.org/10.3748/wjg.v22.i35.7951
  12. miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/SMAD4 expression vol.49, pp.6, 2016, https://doi.org/10.3892/ijo.2016.3746
  13. Differential Sensitivity of Target Genes to Translational Repression by miR-17~92 vol.13, pp.2, 2017, https://doi.org/10.1371/journal.pgen.1006623
  14. miR-19a/b modulates lung cancer cells metastasis through suppression of MXD1 expression vol.12, pp.3, 2016, https://doi.org/10.3892/ol.2016.4881
  15. infection vol.119, pp.9, 2018, https://doi.org/10.1002/jcb.27067